nnnSelection and evaluation of quality markers from Yinlan capsule and its LXRα-mediated therapy for hyperlipidemia
ConclusionsThe YL capsule was demonstrated to have obvious lipid regulatory effects, which are mainly exerted by targeting LXR and its related pathway. Lupeol and ginsenoside Rb3 were validated as Q-markers that represent the anti-hyperlipidemia activity of the capsule.Graphical Abstract
Source: Phytomedicine - Category: Drugs & Pharmacology Source Type: research
More News: China Health | Cholesterol | Computers | Diets | Drugs & Pharmacology | Genetics | High Fat | Liver | Nutrition | Study | Urology & Nephrology